SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-22-032263
Filing Date
2022-06-10
Accepted
2022-06-10 16:40:30
Documents
13
Period of Report
2022-06-09
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea161460-8k_augmedix.htm   iXBRL 8-K 25212
2 THIRD OMNIBUS AMENDMENT, DATED AS OF JUNE 9, 2022, BY AND BETWEEN AUGMEDIX OPERA ea161460ex10-1_augmedix.htm EX-10.1 15023
  Complete submission text file 0001213900-22-032263.txt   218191

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE augx-20220609.xsd EX-101.SCH 2959
4 XBRL LABEL FILE augx-20220609_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE augx-20220609_pre.xml EX-101.PRE 22359
7 EXTRACTED XBRL INSTANCE DOCUMENT ea161460-8k_augmedix_htm.xml XML 3712
Mailing Address 111 SUTTER STREET, SUITE 1300 SAN FRANCISC CA 94104
Business Address 111 SUTTER STREET, SUITE 1300 SAN FRANCISC CA 94104 561-989-2208
Augmedix, Inc. (Filer) CIK: 0001769804 (see all company filings)

IRS No.: 833299164 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40890 | Film No.: 221009499
SIC: 7389 Services-Business Services, NEC